| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5671827 | Clinical Microbiology and Infection | 2017 | 32 Pages |
Abstract
In summary, only 56.6% of ICU patients receiving SAT had CP. Most strains were susceptible to SAT. A similar 28-day mortality rate was observed among groups; the late administration of SAT significantly worsened the prognosis of patients with less severe CP.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
P. Montravers, P.F. Perrigault, J.F. Timsit, J.P. Mira, O. Lortholary, O. Leroy, J.P. Gangneux, D. Guillemot, C. Bensoussan, S. Bailly, E. Azoulay, J.M. Constantin, H. Dupont,